News » DM Zone news » October Cat M prices strip £16.3m per quarter
September 27th 2025
There are now 608 lines in Category M, following nine deletions and three additions. The October prices reduce reimbursement by £16.3 million per quarter, following the latest community pharmacy medicine margin survey results.
The latest results from the quarterly Medicines Margin Survey indicate a total cumulative over delivery of £124m at the end of the January – March 2025 quarter.
Also reflected in the Q3 adjustment are:
In detail:
Nine deletions
|
Betamethasone 500microgram soluble tablets sugar free |
100 |
|
Isosorbide mononitrate 40mg tablets |
56 |
|
Metformin 1g / Sitagliptin 50mg tablets |
56 |
|
Mometasone 0.1% ointment |
30 |
|
Mometasone 0.1% ointment |
100 |
|
Oxybutynin 2.5mg tablets |
56 |
|
Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials |
20 |
|
Ursodeoxycholic acid 250mg capsules |
60 |
|
Venlafaxine 150mg modified-release tablets |
30 |
Three additions
|
Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray |
120 |
|
Sitagliptin 50mg / Metformin 1g tablets |
56 |
|
Venlafaxine 37.5mg modified-release capsules |
28 |
In summary:
DDA members can view a fully updated spreadsheet with prices sorted by price history, price change and % price change. Access the online library of Category M updates